141 related articles for article (PubMed ID: 31083423)
1. The Adductomics of Isolevuglandins: Oxidation of IsoLG Pyrrole Intermediates Generates Pyrrole⁻Pyrrole Crosslinks and Lactams.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
High Throughput; 2019 May; 8(2):. PubMed ID: 31083423
[TBL] [Abstract][Full Text] [Related]
2. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
3. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
[TBL] [Abstract][Full Text] [Related]
4. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
[TBL] [Abstract][Full Text] [Related]
5. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
Salomon RG
Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
[TBL] [Abstract][Full Text] [Related]
6. Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts.
Brame CJ; Salomon RG; Morrow JD; Roberts LJ
J Biol Chem; 1999 May; 274(19):13139-46. PubMed ID: 10224068
[TBL] [Abstract][Full Text] [Related]
7. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.
Li W; Laird JM; Lu L; Roychowdhury S; Nagy LE; Zhou R; Crabb JW; Salomon RG
Free Radic Biol Med; 2009 Dec; 47(11):1539-52. PubMed ID: 19751823
[TBL] [Abstract][Full Text] [Related]
8. Molecular Structures of Isolevuglandin-Protein Cross-Links.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
Chem Res Toxicol; 2016 Oct; 29(10):1628-1640. PubMed ID: 27599534
[TBL] [Abstract][Full Text] [Related]
9. Isolevuglandin adducts in disease.
Salomon RG; Bi W
Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
[TBL] [Abstract][Full Text] [Related]
10. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.
Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL
FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.
Salomon RG
Chem Phys Lipids; 2005 Mar; 134(1):1-20. PubMed ID: 15752459
[TBL] [Abstract][Full Text] [Related]
12. Generation and detection of levuglandins and isolevuglandins in vitro and in vivo.
Zhang M; Li W; Li T
Molecules; 2011 Jun; 16(7):5333-48. PubMed ID: 21705973
[TBL] [Abstract][Full Text] [Related]
13. Oxidized phospholipids, isolevuglandins, and atherosclerosis.
Zhang W; Salomon RG
Mol Nutr Food Res; 2005 Nov; 49(11):1050-62. PubMed ID: 16270278
[TBL] [Abstract][Full Text] [Related]
14. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.
Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K
Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721
[TBL] [Abstract][Full Text] [Related]
15. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein.
Salomon RG; Sha W; Brame C; Kaur K; Subbanagounder G; O'Neil J; Hoff HF; Roberts LJ
J Biol Chem; 1999 Jul; 274(29):20271-80. PubMed ID: 10400646
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry detection of isolevuglandin adduction to specific protein residues.
Charvet CD; Pikuleva IA
Methods Mol Biol; 2015; 1208():285-98. PubMed ID: 25323515
[TBL] [Abstract][Full Text] [Related]
17. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
Salomon RG; Batyreva E; Kaur K; Sprecher DL; Schreiber MJ; Crabb JW; Penn MS; DiCorletoe AM; Hazen SL; Podrez EA
Biochim Biophys Acta; 2000 May; 1485(2-3):225-35. PubMed ID: 10832102
[TBL] [Abstract][Full Text] [Related]
18. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of in vitro pyrrole adduct autoxidation in 2,5-hexanedione-treated protein.
DeCaprio AP
Mol Pharmacol; 1986 Nov; 30(5):452-8. PubMed ID: 3773883
[TBL] [Abstract][Full Text] [Related]
20. Photosensitized oxidations of substituted pyrroles: unanticipated radical-derived oxygenated products.
Alberti MN; Vougioukalakis GC; Orfanopoulos M
J Org Chem; 2009 Oct; 74(19):7274-82. PubMed ID: 19739608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
